US Stock MarketDetailed Quotes

RGBP REGEN BIOPHARMA INC

Watchlist
  • 0.075
  • +0.004+5.19%
15min DelayClose Dec 20 16:00 ET
788.74KMarket Cap-0.71P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-298.54%-693.14K
-536.17%-148.9K
-98.36%-172.59K
-294.64%-209.32K
-1,451.39%-162.34K
71.34%-173.92K
72.56%-23.41K
43.42%-87.01K
40.22%-53.04K
96.25%-10.46K
Net income from continuing operations
-174.99%-867.25K
18.50%-264.9K
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
Operating gains losses
----
----
----
----
----
----
----
----
--0
---1.15K
Other non cash items
-30.12%174.5K
-35.64%161.45K
477.30%4.34K
--4.34K
436,700.00%4.37K
114.22%249.72K
402.37%250.86K
-102.20%-1.15K
--0
-100.00%1
Change In working capital
88.90%-214.15K
-202.52%-52.04K
-502.39%-49.13K
-4,807.59%-91.19K
98.91%-21.79K
38.53%-1.93M
185.99%50.76K
100.02%12.21K
-100.00%1.94K
35.08%-1.99M
-Change in receivables
-137.31%-94.87K
-149.03%-27.73K
-221.48%-27.43K
-152.16%-27.43K
-110.03%-12.3K
817.15%254.27K
19.76%56.55K
181.92%22.58K
290.79%52.58K
544.76%122.58K
-Change in prepaid assets
-75.18%5.2K
262.23%7.5K
-163.26%-7.5K
-89.24%200
-57.83%5K
21.79%20.95K
-47.04%-4.62K
77.19%11.86K
-72.66%1.86K
72.93%11.86K
-Change in payables and accrued expense
-66.46%19.94K
-81.65%2.82K
82.31%17.17K
-314.15%-32.32K
64.67%32.27K
26.39%59.46K
-50.09%15.35K
-46.37%9.42K
-70.92%15.09K
136.86%19.6K
-Change in other current liabilities
99.87%-2.73K
---2.99K
--261
----
----
29.23%-2.15M
--0
--0
-100.05%-35.95K
28.64%-2.12M
-Change in other working capital
-27.15%-141.69K
-91.61%-31.64K
0.00%-31.64K
0.00%-31.64K
-47.81%-46.77K
11.22%-111.43K
47.81%-16.51K
-1.11%-31.64K
-2.25%-31.64K
0.00%-31.64K
Cash from discontinued investing activities
Operating cash flow
-298.55%-693.14K
-536.17%-148.9K
-98.36%-172.59K
-294.64%-209.32K
-1,451.52%-162.34K
71.34%-173.92K
72.56%-23.41K
29.65%-87.01K
55.36%-53.04K
96.25%-10.46K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
135.00%572.82K
-38.95%87.76K
156.32K
62.94%162.94K
165.8K
359.21%243.75K
28,707.62%143.75K
0
100K
0
Net issuance payments of debt
-96.25%9.13K
-58.51%59.64K
--21K
-125.00%-25K
---46.5K
359.21%243.75K
28,707.62%143.75K
--0
--100K
--0
Net common stock issuance
--563.69K
--28.13K
--135.33K
--187.94K
--212.3K
----
----
----
----
--0
Cash from discontinued financing activities
Financing cash flow
135.00%572.82K
-38.95%87.76K
--156.32K
62.94%162.94K
--165.8K
359.21%243.75K
28,707.62%143.75K
--0
--100K
--0
Net cash flow
Beginning cash position
136.38%121.04K
8,837.72%61.85K
-10.93%78.11K
205.58%124.5K
136.38%121.04K
-92.96%51.2K
-99.38%692
-62.63%87.7K
-88.47%40.74K
-92.96%51.2K
Current changes in cash
-272.30%-120.32K
-150.80%-61.13K
81.31%-16.27K
-198.77%-46.38K
133.07%3.46K
110.33%69.83K
301.28%120.35K
29.65%-87.01K
139.52%46.96K
97.20%-10.46K
End cash Position
-99.41%715
-99.41%715
8,837.72%61.85K
-10.93%78.11K
205.58%124.5K
136.38%121.04K
136.38%121.04K
-99.38%692
-62.63%87.7K
-88.47%40.74K
Free cash flow
-298.55%-693.14K
-536.17%-148.9K
-98.36%-172.59K
-294.64%-209.32K
-1,451.52%-162.34K
71.34%-173.92K
72.56%-23.41K
29.65%-87.01K
55.36%-53.04K
96.25%-10.46K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -298.54%-693.14K-536.17%-148.9K-98.36%-172.59K-294.64%-209.32K-1,451.39%-162.34K71.34%-173.92K72.56%-23.41K43.42%-87.01K40.22%-53.04K96.25%-10.46K
Net income from continuing operations -174.99%-867.25K18.50%-264.9K-31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M
Operating gains losses ----------------------------------0---1.15K
Other non cash items -30.12%174.5K-35.64%161.45K477.30%4.34K--4.34K436,700.00%4.37K114.22%249.72K402.37%250.86K-102.20%-1.15K--0-100.00%1
Change In working capital 88.90%-214.15K-202.52%-52.04K-502.39%-49.13K-4,807.59%-91.19K98.91%-21.79K38.53%-1.93M185.99%50.76K100.02%12.21K-100.00%1.94K35.08%-1.99M
-Change in receivables -137.31%-94.87K-149.03%-27.73K-221.48%-27.43K-152.16%-27.43K-110.03%-12.3K817.15%254.27K19.76%56.55K181.92%22.58K290.79%52.58K544.76%122.58K
-Change in prepaid assets -75.18%5.2K262.23%7.5K-163.26%-7.5K-89.24%200-57.83%5K21.79%20.95K-47.04%-4.62K77.19%11.86K-72.66%1.86K72.93%11.86K
-Change in payables and accrued expense -66.46%19.94K-81.65%2.82K82.31%17.17K-314.15%-32.32K64.67%32.27K26.39%59.46K-50.09%15.35K-46.37%9.42K-70.92%15.09K136.86%19.6K
-Change in other current liabilities 99.87%-2.73K---2.99K--261--------29.23%-2.15M--0--0-100.05%-35.95K28.64%-2.12M
-Change in other working capital -27.15%-141.69K-91.61%-31.64K0.00%-31.64K0.00%-31.64K-47.81%-46.77K11.22%-111.43K47.81%-16.51K-1.11%-31.64K-2.25%-31.64K0.00%-31.64K
Cash from discontinued investing activities
Operating cash flow -298.55%-693.14K-536.17%-148.9K-98.36%-172.59K-294.64%-209.32K-1,451.52%-162.34K71.34%-173.92K72.56%-23.41K29.65%-87.01K55.36%-53.04K96.25%-10.46K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 135.00%572.82K-38.95%87.76K156.32K62.94%162.94K165.8K359.21%243.75K28,707.62%143.75K0100K0
Net issuance payments of debt -96.25%9.13K-58.51%59.64K--21K-125.00%-25K---46.5K359.21%243.75K28,707.62%143.75K--0--100K--0
Net common stock issuance --563.69K--28.13K--135.33K--187.94K--212.3K------------------0
Cash from discontinued financing activities
Financing cash flow 135.00%572.82K-38.95%87.76K--156.32K62.94%162.94K--165.8K359.21%243.75K28,707.62%143.75K--0--100K--0
Net cash flow
Beginning cash position 136.38%121.04K8,837.72%61.85K-10.93%78.11K205.58%124.5K136.38%121.04K-92.96%51.2K-99.38%692-62.63%87.7K-88.47%40.74K-92.96%51.2K
Current changes in cash -272.30%-120.32K-150.80%-61.13K81.31%-16.27K-198.77%-46.38K133.07%3.46K110.33%69.83K301.28%120.35K29.65%-87.01K139.52%46.96K97.20%-10.46K
End cash Position -99.41%715-99.41%7158,837.72%61.85K-10.93%78.11K205.58%124.5K136.38%121.04K136.38%121.04K-99.38%692-62.63%87.7K-88.47%40.74K
Free cash flow -298.55%-693.14K-536.17%-148.9K-98.36%-172.59K-294.64%-209.32K-1,451.52%-162.34K71.34%-173.92K72.56%-23.41K29.65%-87.01K55.36%-53.04K96.25%-10.46K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------
Heat List
US
Overall
Symbol
Price
% Chg

No Data